APODAN A/S: Financial statements 2012
CVR: 14123849
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
APODAN A/S (CVR 14123849) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 2,783,051 and a net result of DKK 546,930. Equity in the 2012 report amounted to DKK 3,007,936. The solvency ratio was 37.4%.
- Gross Profit
- DKK 2,783,051
- Profit/Loss
- DKK 546,930
- Equity
- DKK 3,007,936
- Total Assets
- DKK 8,043,710
Official annual report
Keep an eye on APODAN A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of April 30, 2012, Jens Pauli Joensen has joined the board of directors of APODAN A/S.
As of April 30, 2012, Søren Laursen has left the board of directors of APODAN A/S.
About APODAN A/S
APODAN A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 1990. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named APODANNORDIC HEALTHCARE A/S and ROTAVELET A/S. The management consists of Morten Lodberg Petersen. The board consists of Andreas Peter Illum Wildfang von Scholten (chair), Jacob Marcus Emanuel Drakenberg Walberg and Morten Lodberg Petersen. The company is owned by Sanviva Denmark ApS. The company has 15 employees (2026). In 2025, the company reported a gross profit of DKK 14,962,819 and a net result of DKK 3,554,949 compared with DKK 2,573,254 the year before. Equity in the 2025 report amounted to DKK 11,617,033.